These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12133920)

  • 1. Faecal occult blood screening for colorectal cancer.
    Scholefield JH; Moss SM
    J Med Screen; 2002; 9(2):54-5. PubMed ID: 12133920
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?
    Castiglione G
    Gut; 2010 Jan; 59(1):9-10. PubMed ID: 20007956
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal occult blood testing for colorectal cancer.
    McArdle CS
    Ann Oncol; 2002 Jan; 13(1):35-9. PubMed ID: 11863107
    [No Abstract]   [Full Text] [Related]  

  • 5. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for rectal cancer.
    St John DJ
    Hepatogastroenterology; 2000; 47(32):305-9. PubMed ID: 10791177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendation to include colorectal cancer screening in public health policy. The European Group for Colorectal Cancer Screening.
    J Med Screen; 1999; 6(2):80-1. PubMed ID: 10444725
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for colorectal cancer--which strategy is the best?
    Church TR
    J Natl Cancer Inst; 2011 Sep; 103(17):1282-3. PubMed ID: 21852265
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

  • 13. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorectal cancer screening.
    Ederer F; Church T; Mandel J
    Scand J Gastroenterol; 2004 Oct; 39(10):1031-2; author reply 1029-30. PubMed ID: 15513349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evidence-based planning: the case of mass screening for colorectal cancer in the Lazio region of Italy].
    Federici A; Borgia P; Guasticchi G
    Ann Ig; 2005; 17(4):313-22. PubMed ID: 16156391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood testing in the secondary prevention of colorectal cancer.
    Kronborg O
    Eur J Cancer Prev; 2001 Apr; 10(2):167-8. PubMed ID: 11330459
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigmoidoscopy and faecal occult blood test - a comparative screening trial.
    Lange T; Randel KR; Schult AL; Knudsen MD; Kirkøen B; Botteri E; Berstad P; Jørgensen A; Ursin G; Bretthauer M; Hoff G
    Tidsskr Nor Laegeforen; 2017 May; 137(10):727-730. PubMed ID: 28551972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.